Submission Details
| 510(k) Number | K152852 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 29, 2015 |
| Decision Date | December 22, 2015 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K152852 is an FDA 510(k) clearance for the ALEVE Direct Therapy (ALEVE Direct Therapy TENS device), a Stimulator, Nerve, Transcutaneous, Over-the-counter (Class II — Special Controls, product code NUH), submitted by Bayer Healthcare, LLC (Whippany, US). The FDA issued a Cleared decision on December 22, 2015, 84 days after receiving the submission on September 29, 2015. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5890.
| 510(k) Number | K152852 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 29, 2015 |
| Decision Date | December 22, 2015 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | NUH — Stimulator, Nerve, Transcutaneous, Over-the-counter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5890 |
| Definition | Temporary Relief Of Pain Due To Sore/aching Muscles |